Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA

By Marinaro M.   Riccomi A.   Rappuoli R.   Pizza M.   Fiorelli V.   Tripiciano A.   Cafaro A.   Ensoli B.   De Magistris M.T.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3972-3981

Elsevier

Access to resources Recommend Favorite

A novel epitope R7V common to all HIV-1 isolates is recognized by neutralizing IgG found in HIV-infected patients and immunized rabbits

By Galea P.   Le Contel C.   Chermann J.C.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1454-1461

Elsevier

Access to resources Recommend Favorite

HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates

By Davis D.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 353-354

Elsevier

Access to resources Recommend Favorite

Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer

By Mitchell L.A.   Tingle A.J.   Decarie D.   Shukin R.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2356-2365

Elsevier

Access to resources Recommend Favorite

Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein

By Thiesen B.   Greenwood B.   Brieske N.   Achtman M.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 209-219

Elsevier

Access to resources Recommend Favorite